(Q38002888)

English

Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature

scientific article published on 16 April 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

Craig W. Lindsley

1

object named as

Craig W Lindsley

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

author name string

Corey R Hopkins

2

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

language of work or name

0 references

publication date

16 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Expert Opinion on Therapeutic Patents

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

461-481

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Parkinson's disease: mechanisms and models

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Neurobiology and treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Non-motor symptoms of Parkinson's disease: diagnosis and management

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Genetic and environmental factors in the cause of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

On the presence of 3-hydroxytyramine in brain.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

The etiology of Parkinson's disease with emphasis on the MPTP story

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

The levodopa wearing-off phenomenon in Parkinson's disease: pharmacokinetic considerations

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Do dopamine agonists or levodopa modify Parkinson's disease progression?

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Neuroprotective effects of a selective N-methyl-D-aspartate NR2B receptor antagonist in the 6-hydroxydopamine rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Adenosine A(2A) Receptor Antagonists and Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson's Disease.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Small Molecule c-jun-N-terminal Kinase (JNK) Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-hydroxydopamine Model of Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Recent advances in the design and development of novel negative allosteric modulators of mGlu(5)

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

mGluR4-positive allosteric modulation as potential treatment for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Recent progress on the identification of metabotropic glutamate 4 receptor ligands and their potential utility as CNS therapeutics

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Neural mechanisms in disorders of movement.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Primate models of movement disorders of basal ganglia origin

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Functional neurosurgery for movement disorders: a historical perspective

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Pharmacology and functions of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Regulation of neurotransmitter release by metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Distribution of group III mGluRs in rat basal ganglia with subtype-specific antibodies

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

L-(+)-2-Amino-4-thiophosphonobutyric acid (L-thioAP4), a new potent agonist of group III metabotropic glutamate receptors: increased distal acidity affords enhanced potency.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Synthesis and biological evaluation of (2S)- and (2R)-2-(3'-phosphonobicyclo[1.1.1]pentyl)glycines as novel group III selective metabotropic glutamate receptor ligands

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

(-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Re-exploration of the PHCCC Scaffold: Discovery of Improved Positive Allosteric Modulators of mGluR4

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Discovery of molecular switches that modulate modes of metabotropic glutamate receptor subtype 5 (mGlu5) pharmacology in vitro and in vivo within a series of functionalized, regioisomeric 2- and 5-(phenylethynyl)pyrimidines

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: unexpected 'molecular switch' from a closely related mGlu4 positive allosteric modulator

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

"Molecular switches" on mGluR allosteric ligands that modulate modes of pharmacology

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Chemical switch of a metabotropic glutamate receptor 2 silent allosteric modulator into dual metabotropic glutamate receptor 2/3 negative/positive allosteric modulators

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-lead

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS).

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Integrated synthetic, pharmacological, and computational investigation of cis-2-(3,5-dichlorophenylcarbamoyl)cyclohexanecarboxylic acid enantiomers as positive allosteric modulators of metabotropic glutamate receptor subtype 4.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Synthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs)

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Tricyclic thiazolopyrazole derivatives as metabotropic glutamate receptor 4 positive allosteric modulators

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Discovery, synthesis, and structure-activity relationship development of a series of N-4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): characterization of a novel positive allosteric modulator of the metabotropic glutamate recept

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.679437

21 January 2018

Identifiers

10.1517/13543776.2012.679437

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38002888&oldid=1736909031"